First-in-man trial of MERS vaccine begins at Walter Reed Army Institute of Research

(The U.S. Military HIV Research Program (MHRP)) The Walter Reed Army Institute of Research (WRAIR) began vaccinations Tuesday in a Phase 1 clinical trial to evaluate the safety and immune response in humans to a vaccine candidate to prevent Middle East Respiratory Syndrome (MERS).